Literature DB >> 30467844

Exome analysis of treatment-related AML after APL suggests secondary evolution.

Tianjiao Wang1, Meagan A Jacoby1, Eric J Duncavage2, Christopher A Miller3, Sharon Heath1, Ramy Rahme4, Pierre Fenaux4, Lionel Ades4, Aline Renneville5, Bruno Cassinat4, Akihiro Takeshita6, Norio Asou7, Yasushi Miyazaki8, Hitoshi Kiyoi9, Farhad Ravandi10, Peter Westervelt1, Lukas D Wartman1, John S Welch1.   

Abstract

Entities:  

Keywords:  acute leukaemia; acute promyelocytic leukaemia; chemotherapy

Mesh：

Year:  2018        PMID： 30467844      PMCID： PMC6531372          DOI： 10.1111/bjh.15681

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.

Authors:  Mario Ojeda-Uribe; Anne Schneider; Isabelle Luquet; Ana Berceanu; Pascale Cornillet-Lefebvre; Eric Jeandidier; Bruno Lioure; Lionel Ades; Laurent Mauvieux; Chantal Himberlin
Journal:  Eur J Haematol       Date:  2012-06-27       Impact factor: 2.997

Review 2.  Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature.

Authors:  S Zompi; O Legrand; D Bouscary; C M Blanc; F Picard; N Casadevall; F Dreyfus; J P Marie; F Viguié
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

3.  Assessment of Minimal Residual Disease in Standard-Risk AML.

Authors:  Sarah Morin-Zorman; Aline Renneville; Lionel Adès
Journal:  N Engl J Med       Date:  2016-08-11       Impact factor: 91.245

Review 4.  Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.

Authors:  Simona Zompi; Franck Viguié
Journal:  Leuk Lymphoma       Date:  2002-02

Review 5.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

6.  TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  John S Welch; Allegra A Petti; Christopher A Miller; Catrina C Fronick; Michelle O'Laughlin; Robert S Fulton; Richard K Wilson; Jack D Baty; Eric J Duncavage; Bevan Tandon; Yi-Shan Lee; Lukas D Wartman; Geoffrey L Uy; Armin Ghobadi; Michael H Tomasson; Iskra Pusic; Rizwan Romee; Todd A Fehniger; Keith E Stockerl-Goldstein; Ravi Vij; Stephen T Oh; Camille N Abboud; Amanda F Cashen; Mark A Schroeder; Meagan A Jacoby; Sharon E Heath; Kierstin Luber; Megan R Janke; Andrew Hantel; Niloufer Khan; Madina J Sukhanova; Randall W Knoebel; Wendy Stock; Timothy A Graubert; Matthew J Walter; Peter Westervelt; Daniel C Link; John F DiPersio; Timothy J Ley
Journal:  N Engl J Med       Date:  2016-11-24       Impact factor: 91.245

7.  Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.

Authors:  Tae Sung Park; Jong Rak Choi; Sul Hee Yoon; Jaewoo Song; Juwon Kim; Sue Jung Kim; Ohgun Kwon; Yoo Hong Min
Journal:  Cancer Genet Cytogenet       Date:  2008-12

8.  Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Authors:  Jacqueline Lehmann-Che; Cécile Bally; Eric Letouzé; Caroline Berthier; Hao Yuan; Florence Jollivet; Lionel Ades; Bruno Cassinat; Pierre Hirsch; Arnaud Pigneux; Marie-Joelle Mozziconacci; Scott Kogan; Pierre Fenaux; Hugues de Thé
Journal:  Nat Commun       Date:  2018-05-24       Impact factor: 14.919

9.  A case of therapy-related acute myeloid leukemia with a normal karyotype after sustained molecular complete remission of acute promyelocytic leukemia.

Authors:  Sang Hyuk Park; Hyun-Sook Chi; Young-Uk Cho; Seongsoo Jang; Chan-Jeoung Park; Je-Hwan Lee
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.